Return to search

The role of nitric oxide as a hypoxic cell radiosensitizer

Many tumours contain regions of hypoxia which are difficult to treat by conventional radiotherapy. There is much interest in the ability of nitric oxide (<sup>•</sup>NO) to radiosensitize hypoxic mammalian cells as a possible adjunct to radiotherapy but mechanisms for its action are unclear. It has been proposed that <sup>•</sup>NO may radiosensitize cells by ‘fixing’ radiation-induced DNA free radicals, and elevated radiation response by <sup>•</sup>NO in cells has been partly attributed to increased formation of DNA double strand breaks. In the work carried out for this thesis it is shown that reaction of <sup>•</sup>NO with radiation-induced nucleobase radicals produces some novel products. New pathways for the reactions of radiation-induced hydroxyl radicals with purine radicals are proposed. In addition, the effects of <sup>•</sup>NO on the yields of radiation-induced single strand breaks in anoxic plasmid DNA, and on anoxic mammalian cell radiosensitivity are investigated. Kinetics of formation and repair of radiation-induced double strand breaks indicate different effects of <sup>•</sup>NO on radiation-induced clustered and non-clustered DNA damage involving replication-induced DNA breaks. As <sup>•</sup>NO is an inhibitor of ribonucleotide reductase, some of the radiosensitizing properties of <sup>•</sup>NO may be due to reduction in the availability of 2-deoxyribonucleotides. Through studying reactions of <sup>•</sup>NO with tyrosine radicals, essential components of ribonucleotide reductase, this work has enhanced understanding into how <sup>•</sup>NO may inhibit the enzyme, which may offer new insights into the development of <sup>•</sup>NO-releasing anti-cancer agents. The potential for delivery of <sup>•</sup>NO to hypoxic tissue for radiotherapy has also been investigated in this work, through the development of bioreductively-activated pro-drugs. These novel agents are stable until reduced by one-electron reductants, when a <sup>•</sup>NO-releasing pro-drug is rapidly evolved, only in those regions which are sufficiently hypoxic. By increasing our understanding into the mechanisms involved in the ability of <sup>•</sup>NO to radiosensitize hypoxic cells, especially the reactivity of <sup>•</sup>NO with DNA radicals, knowledge has been gained into the identification, development and repair of radiation-induced DNA damage in cells, including clustered damage, in the presence of <sup>•</sup>NO. These studies contribute to further development of novel anti-cancer therapies based upon the release of <sup>•</sup>NO in hypoxic cells.

Identiferoai:union.ndltd.org:bl.uk/oai:ethos.bl.uk:669848
Date January 2013
CreatorsFolkes, Lisa K.
ContributorsO'Neill, Peter ; Vojnovic, Borivoj
PublisherUniversity of Oxford
Source SetsEthos UK
Detected LanguageEnglish
TypeElectronic Thesis or Dissertation
Sourcehttp://ora.ox.ac.uk/objects/uuid:f5ada357-8d85-48fb-8427-158e05d19f8b

Page generated in 0.0021 seconds